BUILDING TOMORROW'S CARE TODAY

The Indian pharma industry is at a juncture where digital transformation is sweeping the healthcare landscape

- NILESH GUPTA

ONE OF THE founders of the Indian pharma industry, my father D.B. Gupta, started Lupin over 55 years ago with the belief that no one should be left without the quality care they deserve. His passion led to the creation of Lupin, a company that provides healthcare to millions of patients and exists for people, not just profits. However, it is five decades later that we now have tools to truly deliver on the purpose of delivering quality healthcare to every patient globally—irrespective of age, background, geography or economic strata.

You see so many instances of what will be the standard of care tomorrow already in use today—AI algorithms today diagnose diseases such as cancer with accuracy; pills embedded with sensors used to share real-time data; AI tools detect anomalies in X-rays and MRIs more accurately than traditional methods.

This juncture that the health-care industry stands at today, is both inspiring and empowering, with digital transformation sweeping the landscape. At the heart of this is one promise—delivering true personalised care. The need of the hour is to now accelerate this through building technologies that work seamlessly, creating the right regulations, and to incentivise innovation.

Harnessing the Trio of AI, Telemedicine, Wearables